Pfizer’s Acquisition of Anacor: Pfizer to get lead asset in derma
Posted on17 May 2016
Tagsanacor, atopic dermatitis, crisaborole, PDE-4 inhibitor, pfizer, Pfizer anacor deal, Pfizer's Acquisition of Anacor
Comments0
Pfizer will acquire Anacor for a total transaction value of $5.2bn (which assumes the conversion of Anacor’s convertible notes). Why this acquisition?... Read More